AORT (AORT)

Financial Metrics & Valuation Analysis

Enterprise Valuation (TTM)

Enterprise Value$1.50B
EV / Sales3.28
EV / EBITDA23.13
EV / Operating Cash Flow26.76
EV / Free Cash Flow117.28

Return Metrics (TTM)

Return on Equity (ROE)2.66%
Return on Assets (ROA)1.32%
Return on Invested Capital (ROIC)3.00%
Return on Capital Employed (ROCE)4.50%

Yield Metrics

Earnings Yield0.91%
Free Cash Flow Yield0.99%

Balance Sheet Strength

Net Debt / EBITDA3.11
Current Ratio3.28
Working Capital$211.40M
Tangible Asset Value$43.92M
Net Current Asset Value-$128.59M

Working Capital Efficiency

Days Sales Outstanding84.05
Days Payables Outstanding39.37
Operating Cycle (Days)294.47
Cash Conversion Cycle255.09

Capital Allocation

CapEx / Revenue9.46%
CapEx / Operating Cash Flow77.18%
R&D / Revenue7.22%
SG&A / Revenue48.16%

Fiscal Year 2025 Ratios

Audited annual results as of 2025-12-31

Margins

Gross Profit Margin61.28%
Operating Margin6.06%
Net Profit Margin2.21%

Solvency

Debt / Equity0.65
Quick Ratio2.08
Cash Ratio0.64

Per Share

Revenue / Share$9.73
FCF / Share-$0.02
PE Ratio207.32